1. Home
  2. ATAI vs KGEI Comparison

ATAI vs KGEI Comparison

Compare ATAI & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • KGEI
  • Stock Information
  • Founded
  • ATAI 2018
  • KGEI 2008
  • Country
  • ATAI Germany
  • KGEI United States
  • Employees
  • ATAI N/A
  • KGEI N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • KGEI
  • Sector
  • ATAI Health Care
  • KGEI
  • Exchange
  • ATAI Nasdaq
  • KGEI Nasdaq
  • Market Cap
  • ATAI 444.7M
  • KGEI 254.9M
  • IPO Year
  • ATAI 2021
  • KGEI N/A
  • Fundamental
  • Price
  • ATAI $2.77
  • KGEI $6.66
  • Analyst Decision
  • ATAI Strong Buy
  • KGEI Strong Buy
  • Analyst Count
  • ATAI 2
  • KGEI 1
  • Target Price
  • ATAI $11.00
  • KGEI $11.00
  • AVG Volume (30 Days)
  • ATAI 5.4M
  • KGEI 446.2K
  • Earning Date
  • ATAI 08-12-2025
  • KGEI 08-12-2025
  • Dividend Yield
  • ATAI N/A
  • KGEI N/A
  • EPS Growth
  • ATAI N/A
  • KGEI 42.32
  • EPS
  • ATAI N/A
  • KGEI 0.57
  • Revenue
  • ATAI $1,863,000.00
  • KGEI $60,739,000.00
  • Revenue This Year
  • ATAI $554.22
  • KGEI $32.19
  • Revenue Next Year
  • ATAI N/A
  • KGEI $33.24
  • P/E Ratio
  • ATAI N/A
  • KGEI $11.42
  • Revenue Growth
  • ATAI 572.56
  • KGEI 20.06
  • 52 Week Low
  • ATAI $1.03
  • KGEI $2.85
  • 52 Week High
  • ATAI $2.96
  • KGEI $9.89
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 67.73
  • KGEI 48.05
  • Support Level
  • ATAI $2.15
  • KGEI $6.47
  • Resistance Level
  • ATAI $2.96
  • KGEI $8.27
  • Average True Range (ATR)
  • ATAI 0.21
  • KGEI 0.50
  • MACD
  • ATAI 0.04
  • KGEI -0.01
  • Stochastic Oscillator
  • ATAI 80.21
  • KGEI 17.78

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About KGEI Kolibri Global Energy Inc. Common stock

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.

Share on Social Networks: